Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 76483-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 76483-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Square Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine Orally Disintegrating Tablets Usp, 15 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 01)

Mirtazapine Orally Disintegrating Tablets Usp, 15 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 01)
Mirtazapine Orally Disintegrating Tablets, USP 15 mg packaging label from Square Pharmaceuticals Limited. The label indicates the tablet strength as 15 mg, oral route, with 30 tablets per package (5 strips of 6 tablets). It includes storage instructions, dosage form, and manufacturer details from Dhaka, Bangladesh.*
FDA Label Image

Mirtazapine Orally Disintegrating Tablets Usp, 30 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 02)

Mirtazapine Orally Disintegrating Tablets Usp, 30 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 02)
Package label for Mirtazapine Orally Disintegrating Tablets, USP 30 mg by Square Pharmaceuticals Limited. The label indicates a unit-of-use package containing 30 tablets (5 blisters of 6 tablets each). It includes storage instructions, a warning about phenylalanine content, and instructions for pharmacists to dispense a medication guide. Manufactured by Square Pharmaceuticals Ltd., Dhaka, Bangladesh.*
FDA Label Image

Mirtazapine Orally Disintegrating Tablets Usp, 45 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 03)

Mirtazapine Orally Disintegrating Tablets Usp, 45 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 03)
Packaging label for Mirtazapine Orally Disintegrating Tablets, USP 45 mg by Square Pharmaceuticals Ltd. The label indicates a tablet dosage form intended for oral use, with a package containing 30 unit-of-use tablets (5 x 6 blisters). The label states it is a once-a-day prescription drug and includes storage information, manufacturer details, and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.